BiotechTube
Home/Cellectis/André Choulika, Ph.D.
AC

André Choulika, Ph.D.

Chief Executive Officer & Director

Cellectis

Therapeutic Areas

OncologyHematological Malignancies

Cellectis Pipeline

DrugIndicationPhase
lasme-cel (UCART22)Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)Phase 2
UCART20x22B-cell MalignanciesPhase 1/2
UCART123Acute Myeloid Leukemia (AML)Phase 1

Leadership Team at Cellectis

SD
Steve Doares, Ph.D.
Senior Vice President, US Manufacturing and Site Head
PD
Philippe Duchateau, Ph.D.
Chief Scientific Officer
AK
Adrian Kilcoyne, MD, MPH, MBA
Chief Medical Officer
View full Cellectis profile